checkpoint inhibitors

Graphic of arrows missing the target
Biotech

Merck's LAG-3 combo fails colorectal cancer phase 3 study

The fixed-dose combination failed to improve overall survival, extending the wait for a checkpoint inhibitor that moves the needle in the indication.
Nick Paul Taylor Sep 25, 2024 8:35am
Colon cancer

ESMO: Innovent links cytokine to colorectal cancer responses

Sep 18, 2024 9:53am
pipeline pipes RD research

Incyte drops two PD-L1 drugs as part of 2nd pipeline clear-out

Jul 30, 2024 8:14am
MA

Boehringer offers up to $1.3B for checkpoint inhibitor biotech

Jul 29, 2024 10:31am
artificial intelligence chip

AI model from NIH, MSKCC predicts immunotherapy responses: study

Jun 4, 2024 12:42pm
An artists concept of chains of amino acides called peptides which together make up polypeptides or proteins

New immunotherapy drug design ups survival in mice with cancer

Apr 23, 2024 3:40am